Skip to main content
Top
Published in: Cancer Causes & Control 4/2014

01-04-2014 | Original paper

Bilateral oophorectomy and risk of cancer in African American women

Authors: Deborah A. Boggs, Julie R. Palmer, Lynn Rosenberg

Published in: Cancer Causes & Control | Issue 4/2014

Login to get access

Abstract

Purpose

African American women are more likely to undergo hysterectomy, with or without bilateral oophorectomy, at younger ages than white women. It is well established that women who have a bilateral oophorectomy at younger ages are at reduced risk of breast cancer, and there is some evidence of an increased risk of colorectal and lung cancer.

Methods

Using data from 44,514 women in the Black Women’s Health Study, we prospectively investigated the relation of hysterectomy and oophorectomy to incidence of breast, colorectal, and lung cancer and to mortality from cancer. Hazard ratios (HRs) and 95 % confidence intervals (CIs) were estimated using Cox proportional hazards regression with control for confounding factors.

Results

During 16 years of follow-up, hysterectomy alone, relative to no hysterectomy, was not associated with risk of breast, lung, or colorectal cancer. Bilateral oophorectomy, relative to hysterectomy with ovarian conservation, was inversely associated with risk of estrogen receptor-positive (ER+) breast cancer (HR 0.62; 95 % CI 0.45–0.85) but not with ER-negative breast cancer; age at surgery and menopausal hormone use did not modify the associations. HRs for the association of bilateral oophorectomy with incidence of colorectal and lung cancer were nonsignificantly increased for women who had surgery before age 40 years and had used menopausal hormones for less than 2 years (HR 1.65; 95 % CI 0.73–3.73 for colorectal cancer and HR 1.71; 95 % CI 0.68–4.31 for lung cancer). Bilateral oophorectomy was not associated with cancer mortality.

Conclusions

Bilateral oophorectomy was associated with reduced risk of ER+ breast cancer regardless of age at surgery and use of menopausal hormones. There were nonsignificant increases in risk of colorectal and lung cancer for women with oophorectomy at younger ages and short duration of menopausal hormone use.
Literature
1.
go back to reference Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM et al (2008) Inpatient hysterectomy surveillance in the United States, 2000–2004. Am J Obstet Gynecol 198(34):e1–e7PubMed Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM et al (2008) Inpatient hysterectomy surveillance in the United States, 2000–2004. Am J Obstet Gynecol 198(34):e1–e7PubMed
2.
go back to reference Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS (2005) Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 106:219–226PubMedCrossRef Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS (2005) Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 106:219–226PubMedCrossRef
3.
go back to reference Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd (2006) Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 7:821–828PubMedCrossRef Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd (2006) Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 7:821–828PubMedCrossRef
4.
go back to reference Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z et al (2009) Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health study. Obstet Gynecol 113:1027–1037PubMedCentralPubMedCrossRef Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z et al (2009) Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health study. Obstet Gynecol 113:1027–1037PubMedCentralPubMedCrossRef
5.
go back to reference Jacoby VL, Grady D, Wactawski-Wende J, Manson JE, Allison MA, Kuppermann M et al (2011) Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women’s Health Initiative Observational Study. Arch Intern Med 171:760–768PubMedCrossRef Jacoby VL, Grady D, Wactawski-Wende J, Manson JE, Allison MA, Kuppermann M et al (2011) Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women’s Health Initiative Observational Study. Arch Intern Med 171:760–768PubMedCrossRef
6.
go back to reference Duan L, Xu X, Koebnick C, Lacey JV Jr, Sullivan-Halley J, Templeman C et al (2012) Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study. Fertil Steril 97:111–117PubMedCentralPubMedCrossRef Duan L, Xu X, Koebnick C, Lacey JV Jr, Sullivan-Halley J, Templeman C et al (2012) Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study. Fertil Steril 97:111–117PubMedCentralPubMedCrossRef
7.
go back to reference Nichols HB, Trentham-Dietz A, Newcomb PA, Titus LJ, Egan KM, Hampton JM et al (2012) Postoophorectomy estrogen use and breast cancer risk. Obstet Gynecol 120:27–36PubMedCentralPubMedCrossRef Nichols HB, Trentham-Dietz A, Newcomb PA, Titus LJ, Egan KM, Hampton JM et al (2012) Postoophorectomy estrogen use and breast cancer risk. Obstet Gynecol 120:27–36PubMedCentralPubMedCrossRef
8.
go back to reference Trichopoulos D, MacMahon B, Cole P (1972) Menopause and breast cancer risk. J Natl Cancer Inst 48:605–613PubMed Trichopoulos D, MacMahon B, Cole P (1972) Menopause and breast cancer risk. J Natl Cancer Inst 48:605–613PubMed
9.
go back to reference Irwin KL, Lee NC, Peterson HB, Rubin GL, Wingo PA, Mandel MG (1988) Hysterectomy, tubal sterilization, and the risk of breast cancer. Am J Epidemiol 127:1192–1201PubMed Irwin KL, Lee NC, Peterson HB, Rubin GL, Wingo PA, Mandel MG (1988) Hysterectomy, tubal sterilization, and the risk of breast cancer. Am J Epidemiol 127:1192–1201PubMed
10.
go back to reference Parazzini F, Braga C, La Vecchia C, Negri E, Acerboni S, Franceschi S (1997) Hysterectomy, oophorectomy in premenopause, and risk of breast cancer. Obstet Gynecol 90:453–456PubMedCrossRef Parazzini F, Braga C, La Vecchia C, Negri E, Acerboni S, Franceschi S (1997) Hysterectomy, oophorectomy in premenopause, and risk of breast cancer. Obstet Gynecol 90:453–456PubMedCrossRef
11.
go back to reference Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA (1997) Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70:150–154PubMedCrossRef Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA (1997) Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70:150–154PubMedCrossRef
12.
go back to reference Kreiger N, Sloan M, Cotterchio M, Kirsh V (1999) The risk of breast cancer following reproductive surgery. Eur J Cancer 35:97–101PubMedCrossRef Kreiger N, Sloan M, Cotterchio M, Kirsh V (1999) The risk of breast cancer following reproductive surgery. Eur J Cancer 35:97–101PubMedCrossRef
13.
go back to reference Press DJ, Sullivan-Halley J, Ursin G, Deapen D, McDonald JA, Strom BL et al (2011) Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women’s contraceptive and reproductive experiences study. Am J Epidemiol 173:38–47PubMedCentralPubMedCrossRef Press DJ, Sullivan-Halley J, Ursin G, Deapen D, McDonald JA, Strom BL et al (2011) Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women’s contraceptive and reproductive experiences study. Am J Epidemiol 173:38–47PubMedCentralPubMedCrossRef
14.
go back to reference Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113:1521–1526PubMedCentralPubMedCrossRef Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113:1521–1526PubMedCentralPubMedCrossRef
15.
go back to reference Jacobs EJ, White E, Weiss NS (1994) Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 5:359–366PubMedCrossRef Jacobs EJ, White E, Weiss NS (1994) Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 5:359–366PubMedCrossRef
16.
go back to reference Gallagher LG, Rosenblatt KA, Ray RM, Li W, Gao DL, Applebaum KM et al (2013) Reproductive factors and risk of lung cancer in female textile workers in Shanghai, China. Cancer Causes Control 24:1305–1314PubMedCrossRef Gallagher LG, Rosenblatt KA, Ray RM, Li W, Gao DL, Applebaum KM et al (2013) Reproductive factors and risk of lung cancer in female textile workers in Shanghai, China. Cancer Causes Control 24:1305–1314PubMedCrossRef
17.
go back to reference Brinton LA, Gierach GL, Andaya A, Park Y, Schatzkin A, Hollenbeck AR et al (2011) Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev 20:900–911PubMedCentralPubMedCrossRef Brinton LA, Gierach GL, Andaya A, Park Y, Schatzkin A, Hollenbeck AR et al (2011) Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev 20:900–911PubMedCentralPubMedCrossRef
18.
go back to reference Koushik A, Parent ME, Siemiatycki J (2009) Characteristics of menstruation and pregnancy and the risk of lung cancer in women. Int J Cancer 125:2428–2433PubMedCrossRef Koushik A, Parent ME, Siemiatycki J (2009) Characteristics of menstruation and pregnancy and the risk of lung cancer in women. Int J Cancer 125:2428–2433PubMedCrossRef
19.
go back to reference Johnson JR, Lacey JV Jr, Lazovich D, Geller MA, Schairer C, Schatzkin A et al (2009) Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 18:196–203PubMedCentralPubMedCrossRef Johnson JR, Lacey JV Jr, Lazovich D, Geller MA, Schairer C, Schatzkin A et al (2009) Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 18:196–203PubMedCentralPubMedCrossRef
20.
go back to reference Delellis Henderson K, Duan L, Sullivan-Halley J, Ma H, Clarke CA, Neuhausen SL et al (2010) Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study. Am J Epidemiol 171:415–425PubMedCentralPubMedCrossRef Delellis Henderson K, Duan L, Sullivan-Halley J, Ma H, Clarke CA, Neuhausen SL et al (2010) Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study. Am J Epidemiol 171:415–425PubMedCentralPubMedCrossRef
21.
go back to reference Rodriguez C, Spencer Feigelson H, Deka A, Patel AV, Jacobs EJ, Thun MJ et al (2008) Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 17:655–660PubMedCrossRef Rodriguez C, Spencer Feigelson H, Deka A, Patel AV, Jacobs EJ, Thun MJ et al (2008) Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 17:655–660PubMedCrossRef
22.
go back to reference Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC et al (2007) Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol 25:5785–5792PubMedCrossRef Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC et al (2007) Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol 25:5785–5792PubMedCrossRef
23.
go back to reference Powell LH, Meyer P, Weiss G, Matthews KA, Santoro N, Randolph JF Jr et al (2005) Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues 15:179–186PubMedCrossRef Powell LH, Meyer P, Weiss G, Matthews KA, Santoro N, Randolph JF Jr et al (2005) Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues 15:179–186PubMedCrossRef
24.
go back to reference Bower JK, Schreiner PJ, Sternfeld B, Lewis CE (2009) Black-White differences in hysterectomy prevalence: the CARDIA study. Am J Public Health 99:300–307PubMedCentralPubMedCrossRef Bower JK, Schreiner PJ, Sternfeld B, Lewis CE (2009) Black-White differences in hysterectomy prevalence: the CARDIA study. Am J Public Health 99:300–307PubMedCentralPubMedCrossRef
25.
go back to reference Kjerulff KH, Guzinski GM, Langenberg PW, Stolley PD, Moye NE, Kazandjian VA (1993) Hysterectomy and race. Obstet Gynecol 82:757–764PubMed Kjerulff KH, Guzinski GM, Langenberg PW, Stolley PD, Moye NE, Kazandjian VA (1993) Hysterectomy and race. Obstet Gynecol 82:757–764PubMed
26.
go back to reference Perera HK, Ananth CV, Richards CA, Neugut AI, Lewin SN, Lu YS et al (2013) Variation in ovarian conservation in women undergoing hysterectomy for benign indications. Obstet Gynecol 121:717–726PubMedCrossRef Perera HK, Ananth CV, Richards CA, Neugut AI, Lewin SN, Lu YS et al (2013) Variation in ovarian conservation in women undergoing hysterectomy for benign indications. Obstet Gynecol 121:717–726PubMedCrossRef
27.
28.
go back to reference Palmer JR, Wise LA, Horton NJ, Adams-Campbell LL, Rosenberg L (2003) Dual effect of parity on breast cancer risk in African–American women. J Natl Cancer Inst 95:478–483PubMedCrossRef Palmer JR, Wise LA, Horton NJ, Adams-Campbell LL, Rosenberg L (2003) Dual effect of parity on breast cancer risk in African–American women. J Natl Cancer Inst 95:478–483PubMedCrossRef
29.
go back to reference Woolcott CG, Maskarinec G, Pike MC, Henderson BE, Wilkens LR, Kolonel LN (2009) Breast cancer risk and hysterectomy status: the Multiethnic Cohort study. Cancer Causes Control 20:539–547PubMedCentralPubMedCrossRef Woolcott CG, Maskarinec G, Pike MC, Henderson BE, Wilkens LR, Kolonel LN (2009) Breast cancer risk and hysterectomy status: the Multiethnic Cohort study. Cancer Causes Control 20:539–547PubMedCentralPubMedCrossRef
30.
go back to reference Parker WH, Feskanich D, Broder MS, Chang E, Shoupe D, Farquhar CM et al (2013) Long-term mortality associated with oophorectomy compared with ovarian conservation in the Nurses’ Health Study. Obstet Gynecol 121:709–716PubMedCrossRef Parker WH, Feskanich D, Broder MS, Chang E, Shoupe D, Farquhar CM et al (2013) Long-term mortality associated with oophorectomy compared with ovarian conservation in the Nurses’ Health Study. Obstet Gynecol 121:709–716PubMedCrossRef
32.
go back to reference Weiss JM, Lacey JV Jr, Shu XO, Ji BT, Hou L, Yang G et al (2008) Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 168:1319–1325PubMedCrossRef Weiss JM, Lacey JV Jr, Shu XO, Ji BT, Hou L, Yang G et al (2008) Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 168:1319–1325PubMedCrossRef
33.
go back to reference Baik CS, Strauss GM, Speizer FE, Feskanich D (2010) Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses’ Health Study. Cancer Epidemiol Biomarkers Prev 19:2525–2533PubMedCentralPubMedCrossRef Baik CS, Strauss GM, Speizer FE, Feskanich D (2010) Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses’ Health Study. Cancer Epidemiol Biomarkers Prev 19:2525–2533PubMedCentralPubMedCrossRef
34.
go back to reference Phipps AI, Buist DS (2009) Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause 16:576–581PubMedCentralPubMedCrossRef Phipps AI, Buist DS (2009) Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause 16:576–581PubMedCentralPubMedCrossRef
Metadata
Title
Bilateral oophorectomy and risk of cancer in African American women
Authors
Deborah A. Boggs
Julie R. Palmer
Lynn Rosenberg
Publication date
01-04-2014
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 4/2014
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0353-y

Other articles of this Issue 4/2014

Cancer Causes & Control 4/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine